Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential

Carcinogenesis

Volumn 32, Issue 2, 2011, Pages 146-153

  Wang, Peng ^a   Wu, Fang ^a   Zhang, Jingdong ^a   McMullen, Todd ^a   Young, Leah C ^a   Ingham, Robert J ^a   Li, Liang ^a   Lai, Raymond ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CASEIN KINASE I; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEOPHOSMIN; SERINE; STAT6 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TYROSINE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 79251546104     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq229     Document Type: Article

References (50)

1. Morris,S.W. et al. (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science, 263, 1281-1284.
2. Delsol,G. et al. (2001) Pathology and genetics tumors of haematopoietic and lymphoid tissues. In Jaffe, E.S., Harris N.L., Stem, H., and Vardiman, J., (eds.) World Health Organization Classification of tumors. IARC press, Lyon, France, pp. 230-235.
3. Donella-Deana, A. et al. (2005) Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry, 44, 8533-8542.
4. Zhang, B. et al. (1991) The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids. J. Biol. Chem., 266, 990-996.
5. Wang, P. et al. (2009) Functional characterization of the kinase activation loop in nucleophosmin (NPM) -anaplastic lymphoma kinase (ALK) using tandem affinity purification and liquid chromatography-mass spectrometry. J. Biol. Chem, 285, 95-103.
6. Piva,R. et al. (2006) Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood, 107, 689-697.
7. Wan,W. et al. (2006) Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells. Blood, 107, 1617-1623.
8. Han,Y. et al. (2006) Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood, 108, 2796-2803.
9. Slupianek,A. et al. (2001) Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis. Cancer Res., 61, 2194-2199.
10. Slupianek,A. et al. (2004) NPM/ALK downregulates p27Kip1 in a PI-3K-dependent manner. Exp. Hematol., 32, 1265-1271.
11. Turner,S.D. et al. (2007) The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms. Cell Signal., 19, 740-747.
12. Marzec,M. et al. (2007) Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Oncogene, 26, 5606-5614.
13. Marzec,M. et al. (2007) Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Oncogene, 26, 813-821.
14. Leventaki,V. et al. (2007) NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic largecell lymphoma. Blood, 110, 1621-1630.
15. Amin,H.M. et al. (2007) Pathobiology of ALK+ anaplastic large-cell lymphoma. Blood, 110, 2259-2267.
16. Falini,B. et al. (2007) Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica, 92, 519-532.
17. Yeh,H.H. et al. (2009) Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell. DNA Cell Biol, 28, 131-139.
18. Wood,N.T. et al. (2009) 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2-potential interplay with the PKB/Akt pathway and p14(ARF). FEBS Lett., 583, 615-620.
19. Mielke,K. (2008) Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells. Mol. Cell. Neurosci., 38, 301-311.
20. Qiao,M. et al. (2008) Metastasis and AKT activation. Cell Cycle, 7, 2991-2996.
21. Qin,H.R. et al. (2008) Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res., 68, 7736-7741.
22. Wissing,J. et al. (2007) Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry. Mol. Cell. Proteomics, 6, 537-547.
23. Daub,H. et al. (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell, 31, 438-448.
24. Wu,F. et al. (2009) Proteome-wide identification of novel binding partners to the oncogenic fusion gene protein, NPM-ALK, using tandem affinity purification and mass spectrometry. Am. J. Pathol., 174, 361-370.
25. Xiang,J. et al. (2008) Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS One, 3, e2580.
26. Wang,P. et al. (2009) Targeted quantitative mass spectrometric identification of differentially expressed proteins between Bax-expressing and deficient colorectal carcinoma cells. J. Proteome. Res., 8, 3403-3414.
27. Wang,N. et al. (2007) Proteome profile of cytosolic component of zebrafish liver generated by LC-ESI MS/MS combined with trypsin digestion and microwave-assisted acid hydrolysis. J. Proteome. Res., 6, 263-272.
28. Tagwerker,C. et al. (2006) A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivocross-linking. Mol. Cell. Proteomics., 5, 737-748.
29. Rush,J. et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol., 23, 94-101.
30. Doucette,A. et al. (2000) Protein concentration and enzyme digestion on microbeads for MALDI-TOF peptide mass mapping of proteins from dilute solutions. Anal. Chem., 72, 3355-3362.
31. Doucette,A. et al. (2003) Mass spectrometric study of the effects of hydrophobic surface chemistry and morphology on the digestion of surfacebound proteins. J. Am. Soc. Mass Spectrom., 14, 203-214.
32. Wang,N. et al. (2009) Off-line two-dimensional liquid chromatography with maximized sample loading to reversed-phase liquid chromatographyelectrospray ionization tandem mass spectrometry for shotgun proteome analysis. Anal. Chem., 81, 1049-1060.
33. Wang,N. et al. (2008) Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis. Anal. Chem., 80, 4696-4710.
34. Bard,J.D. et al. (2008) Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia, 22, 1595-1603.
35. Gould,C.M. et al. (2009) ELM: the status of the 2010 eukaryotic linear motif resource. Nucleic Acids Res, 38, D167-D180.
36. Rena,G. et al. (2004) D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep., 5, 60-65.
37. Yanagita,T. et al. (2007) Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells. Neuropharmacology, 53, 881-889.
38. Song,J.H. et al. (2005) Interferon gamma induces neurite outgrowth by upregulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J. Biol. Chem., 280, 12896-12901.
39. Fukumoto,S. et al. (2006) Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J. Biol. Chem., 281, 5008-5016.
40. Bennett,B.L. et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA, 98, 13681-13686.
41. Boccalatte,F.E. et al. (2009) The enzymatic activity of 5-aminoimidazole4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL. Blood, 113, 2776-2790.
42. Aggarwal,B.B. et al. (2009) Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann. N. Y. Acad. Sci., 1171, 59-76.
43. Yokogami,K. et al. (2000) Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr. Biol., 10, 47-50.
44. Crane,E.D. et al. (2009) Active immune response protects Stat6VT transgenic mice from developing a lymphoproliferative disorder. Immunobiology, 215, 579-585.
45. Woetmann,A. et al. (2003) Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling. J. Biol. Chem., 278, 2787-2791.
46. Wu,G. et al. (2009) Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6. PLoS One, 4, e4926.
47. Ferrarese,A. et al. (2007) Chemical dissection of the APC Repeat 3 multistep phosphorylation by the concerted action of protein kinases CK1 and GSK3. Biochemistry, 46, 11902-11910.
48. Bustos,V.H. et al. (2006) The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc. Natl Acad. Sci. USA, 103, 19725-19730.
49. Umar,S. et al. (2007) Dual alterations in casein kinase I-epsilon and GSK-3beta modulate beta-catenin stability in hyperproliferating colonic epithelia. Am. J. Physiol. Gastrointest. Liver Physiol., 292, G599-G607.
50. Yamamoto,R. et al. (2009) B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma. Cancer Sci., 100, 2093-2100.